Today’s health-care marketplace includes what is known as “direct-to-consumer” genetic testing, through which consumers can buy genetic tests directly from private companies rather than their health care providers. This practice brings with it a new set of technical, legal, policy and ethical questions in regard to regulation of the tests and privacy concerns.
A day-long public workshop hosted by the National Academy of Sciences in Washington, D.C. tackled these topics, assembling representatives from science, medicine, law and policy makers along with members of the public.
Among those representatives was Andrea Ferreira-Gonzalez, Ph.D., professor of pathology and director of the Molecular Diagnostics Lab at the VCU Medical Center.
The forum was aired on C-SPAN on September 6, 2009 and is now available on the cable channel’s Web site. The link below will take you directly to Panel 2, in which Dr. Ferreira-Gonzalez participated. Watch C-SPAN’s coverage.